List of medical beauty concept stocks, which are the leading stocks of medical beauty concept stocks?

The concept of medical beauty is a hot track with high attention recently, but many stock friends don't know what the concept of medical beauty is. Today, Wealth Manager combs out the list of leading stocks with the concept of medical beauty for stock investors for your reference.

Jindawei (002626)

Xiamen Jindawei (002626) Group Co., Ltd.' s main business is the production and sales of nutritional and health food raw materials, pharmaceutical raw materials and nutritional and health food end products. The company's main products are coenzyme Q 10 series, vitamin A series, vitamin D3 series, vitamin K2 series, microalgae DHA, plant ARA and so on. The company and its wholly-owned subsidiaries have obtained 9 patent certificates (7 invention patents and 2 utility model patents).

East China Medicine (000963)

The main business of Huadong Pharmaceutical (000963) Co., Ltd. covers the whole pharmaceutical industry chain, with the pharmaceutical industry as the leading factor, and at the same time, it expands the pharmaceutical business and medical beauty industry, integrating pharmaceutical R&D, production and distribution. The medical beauty industry focuses on the research, development, production and sales of non-surgical mainstream medical beauty products such as facial fillers, body shaping, catgut embedding and energy devices. The company's main products are western medicine and traditional Chinese medicine, medical devices, differentiated sodium hyaluronate product portfolio, collagen stimulator, botulinum toxin A, implant line, energy equipment and so on. The company's two microbial drugs, cyclosporine and acarbose, both won the second prize of the National Science and Technology Progress Award, and the pharmaceutical business is among the best in Zhejiang Province, with strong comprehensive large-scale pharmaceutical industry service providers.

Huilong stock (002556)

Anhui Huilong Agricultural Resources Group Co., Ltd. is mainly engaged in the domestic and international trade and distribution of chemical fertilizers, chemicals and pesticide products. The company's main products include nitrogen fertilizer, potassium fertilizer and compound fertilizer. The company is an advocate of agricultural chain management in China, initiated the listing of agricultural circulation enterprises in the national supply and marketing cooperatives system, and is the leader and practitioner of "China Modern Agricultural Integrated Service Provider". The comprehensive competitiveness ranks fourth in China, and it has won the honorary titles of "Outstanding Contribution Award for 20th Anniversary of Fertilizer Circulation System Reform in China", "No.487 in Fortune China 500" and "China Famous Trademark".

Fuji Lai (30 1258)

Suzhou Fushilai Pharmaceutical Co., Ltd. is mainly engaged in the research, development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. Main products include lipoic acid series, phosphatidylcholine series and carnosine series. The company has successively won the first prize of Suzhou Science and Technology Progress Award, the second prize of Shanghai Science and Technology Progress Award and the first prize of Shanghai Science and Technology Progress Award.

Xinhua Pharmaceutical (000756)(000756)

Shandong Xinhua Pharmaceutical Co., Ltd. is mainly engaged in the development, manufacture and sales of chemical raw materials, preparations and chemical products; The company's main products are antipyretic and analgesic raw materials, tablets, injections, capsules and pharmaceutical intermediates. With the advantages of technological innovation, the company is now a high-tech enterprise, a key high-tech enterprise of the National Torch Program, a backbone enterprise of the biomedical industrial base of the National Torch Program, a national enterprise technology center and an enterprise postdoctoral research center. "Green preparation system construction and large-scale development of caffeine based on key industrialization technologies" won the second prize of Shandong Science and Technology Progress 20 18. Patents granted in the first half of the year 10. The company was promoted as "Shandong Province Technology Innovation Demonstration Enterprise" and was rated as an advanced unit of talent work in Shandong Province.

Fang La Jahwa (603630)(603630)

Fang La Jahwa Co., Ltd. is mainly engaged in research and development, production and sales of toiletries, skin care products and cosmetics. During the reporting period, the company continued to carry out product innovation, brand category matrix construction and marketing channel network update and upgrade. The main products are cream, conditioner, shower gel, shampoo, soap, gel water and gel cream.

Aier Ophthalmology (3000 15)(3000 15)

Aier Eye Hospital Group Co., Ltd. is an ophthalmic medical institution, mainly engaged in the diagnosis and treatment of various ophthalmic diseases, surgical services and medical optometry. The company hosted 20 19 International Retina Summit Forum, International Refraction Forum, Smart Medical Summit Forum and other academic conferences, released the "China Eye Fundus Lesions Big Data Report", and successfully won the right to host the 2023 19 World Myopia Conference.

Langzi shares (0026 12)(0026 12)

Langzi Co., Ltd. is a pure women's clothing enterprise dedicated to the high-end women's clothing market. Its main business is the design, production and sales of branded women's wear. The company's three core brands include its own brands "Prodigal Son" and "Rheinland", as well as the "Zhuo Ke" brand series which is exclusively authorized in China. The main products and services are women's blouses, women's trousers, women's skirts, women's coats, baby clothes, baby products, surgical medical beauty, non-surgical medical beauty and consulting services. The company has obtained 2 national invention patents, 30 software copyrights, 2 design patents 12 and 3 utility model patents 13.

Taiji Group (600 129)(600 129)

Chongqing Taiji Industry (600667) (Group) Co., Ltd. is mainly engaged in the production and sales of Chinese and western medicines. The company's main products are Huoxiang Zhengqi Oral Liquid, Cefotaxime Sodium for Injection (Yibaoshiling), Lofencoine Sustained-release Tablets (Siweipu), Xiaojin Tablets, Morphine Hydrochloride Sustained-release Tablets (Mefeikang), Rosiglitazone Sodium Tablets (Tailuo), Jizhi Syrup, Compound Banlangen Granules, Tian Tong Oral Liquid, Sodium Chloride Injection, Sinusitis Oral Liquid, Liuwei Dihuang Pills, Xuanmai Ganju Granules and Chenxiang Huaqi. The company is one of the largest enterprise groups in China with the most complete pharmaceutical industry chain. "Taiji" is the first batch of well-known trademarks in China, ranking first among OTC brand pharmaceutical companies; "Tongjunge" is a century-old brand, and the traditional pill-making skills of Tongjunge have entered the national intangible cultural heritage. ...

Yunnan Baiyao (000538) Group Co., Ltd. is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines and biological products. The company's products are mainly Yunnan Baiyao series, Sanqi series and Yunnan ethnic medicine series, with more than 200 products in 17 dosage form. Products sell well in the domestic market and Southeast Asia, and gradually enter the markets of developed countries such as Japan, Europe and America. The company is one of the well-known Chinese patent medicine manufacturers in China, one of the large industrial and commercial pharmaceutical enterprises in Yunnan, and one of the top 50 Chinese patent medicines in China. 1997 was recognized as one of the first 40 large enterprises and groups in Yunnan province. Yunnan Baiyao ranks first among the top ten traditional brands of Chinese medicine enterprises in the list of top ten enterprises in various fields of Chinese medicine industry released for the first time by the brand selection activity of 20 10 Chinese medicine industry brand summit. 20 17 September, Yunnan Baiyao was selected as "20 16" issued by China Pharmaceutical (600056) Industrial Information Center. ...